薬で高血圧のコレステロール値を下げる. 薬理学的管理の費用対効果について
K A Schulman1, B Kinosian, T A Jacobson
1Department of Medicine, Robert Wood Johnson Foundation Clinical Scholars Program, University of Pennsylvania, Philadelphia.
JAMA
|December 19, 1990
まとめ
ナイアシンとロバスタチンは,高コレステロールを管理するための最も費用対効果の高い薬であり,低密度リポタンパク質コレステロールと心血管疾患のリスクを大幅に減らすことができます.
科学分野:
- 心血管医学は,心臓血管医学である.
- 健康経済学 医療経済学
- 薬理学 薬理学とは
背景:
- 高血中コレステロールレベルは,心血管疾患の重要な危険因子です.
- 薬理学的介入は,通常,脂質不全症の管理に使用されます.
- 異なる脂質低下剤の費用対効果を評価することは,臨床意思決定において極めて重要です.
研究 の 目的:
- 高血圧コレステロールに対する様々な薬理学的治療法の費用対効果の分析を行う.
- 低密度リポプロテインコレステロール (LDL-C) と高密度リポプロテインコレステロール (HDL-C) のレベルを変更する際の異なる薬剤の効率を比較する.
- 総合的な心血管疾患リスクを減らすための最も費用対効果の高い治療法を特定する.
主な方法:
- コレスティラミン,コレスチポール,ゲンフィブロジル,ロバスタチン,ニアシン,プロブコルなどの費用対効果をモデル化した.
- 既存の出版研究から推定された薬理学的有効性.
- 各セラピーの社会的資源消費を反映した計算されたコスト.
主要な成果:
- ナイアシンは,LDL-Cを減らすのに最も高い効率性を示した (5年間で139ドル/%の減少).
- ローバスタチン (20 mg/d) も高効率で (17%減少177ドル),コレステラミンは最も低効率で (34%減少347ドル) でした.
- HDL-Cを増加させるのに最も効果的だったのはナイアシン (116ドル/%増加),次にゲムフィブロジル (271ドル/%増加) でした.
結論:
- ナイアシンとロバスタチン (20 mg/d) は,コレステロールを管理するための最も費用対効果の高い薬剤として浮上しています.
- これらの薬剤は,脂質プロフィールを改善し,心血管疾患のリスクを軽減する上で最も高い効率性を示しています.
- この発見は,コレステロール管理戦略において,ナイアシンと低用量ロバスタチンの使用を支持する.
関連する概念動画
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...


